-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
15 Jun 2025 14:00 GMT
… on behalf of investors of Gilead Sciences, Inc. (“Gilead” or the “Company …
-
ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & More
16 Jun 2025 02:20 GMT
… of at least six months.
—Gilead Sciences’ Trodelvy, a TROP2-targeting ADC …
-
A short ride on the Remdesivir trail of tears
15 Jun 2025 20:33 GMT
… . It was created by Gilead Sciences, first as a treatment … the major investors are in Gilead Sciences. What did I find? … links between the WEF and Gilead Sciences. I found Harald Nusser, … this statement: To date, Gilead Sciences Inc's intravenous drug …
-
Is there a better to develop new drugs?
15 Jun 2025 19:02 GMT
… . For instance, US biopharmaceutical company Gilead Sciences didn’t discover sofosbuvir – an …
-
Can a $10,000 Investment in CRISPR Therapeutics Turn Into $1 Million?
15 Jun 2025 13:08 GMT
… as Amgen (NASDAQ:AMGN) and Gilead Sciences (NASDAQ:GILD), suggest that a …
-
Wexford duo shine at Bord Bia Bloom 2025 launch
15 Jun 2025 07:54 GMT
… Marie Keating Foundation, AstraZeneca and Gilead Sciences, who are united in their …
-
IRAKLIA Data Support Subcutaneous Isatuximab as a SOC Administration Approach in Myeloma
14 Jun 2025 21:05 GMT
… for AbbVie, Amgen, BMS, GSK, Gilead Sciences, Janssen-Cilag, Novartis, Roche, and …
-
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 Jun 2025 20:01 GMT
… programs under collaboration agreements with Gilead Sciences, Inc., Sanofi S.A. and …
-
Cytokine Release Syndrome Management Global Market Report 2025: Stellar Market To At 6.8% CAGR To $23.83 Billion By 2025
13 Jun 2025 12:54 GMT
… AG, GlaxoSmithKline plc, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Genentech …
-
North America Metabolic Dysfunction Associated Steatohepatitis (MASH) Treatment Market Trends | Growth Forecast 2025
13 Jun 2025 12:45 GMT
… and metabolic parameters.
September 2024 – Gilead Sciences partnered with a leading AI …